Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia
- Conditions
- Parkinson's Disease
- Registration Number
- NCT00912977
- Lead Sponsor
- Oregon Health and Science University
- Brief Summary
Nearly all Parkinson's disease (PD) patients eventually develop abnormal and unwanted movements (dyskinesias; LID) caused by the gold standard treatment, Levodopa. The severity of these movements can range from subtle to extremely debilitating and may or may not interfere with normal activities such as putting on a coat or brushing ones teeth. The purpose of this study is to demonstrate the validity and reliability of objectively measuring dyskinesia with a forceplate.
- Detailed Description
The main outcome measure of this study are measurements taken every half hour during an inpatient study visit. These measurements include standing on a forceplate for 1 minute while performing a mental task such as reciting the alphabet backwards. During this forceplate stance, a rater will visually score your movements. All participants must be eligible for another Parkinson's disease study at Oregon Health and Science University.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 10
- Parkinsons disease
- Older than 18
- Must be participating in a Parkinsons disease study at Oregon Health & Science University
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forceplate Measure Every 1/2 hour
- Secondary Outcome Measures
Name Time Method Visual Rating Scale every 1/2 hour
Trial Locations
- Locations (1)
Oregon Health & Science University
🇺🇸Portland, Oregon, United States